Human Polyomavirus JCPyV and Its Role in Progressive Multifocal Leukoencephalopathy and Oncogenesis

Area of Science:

• Virology
• Oncology
• Neuroscience

Background:

• The human polyomavirus JCPyV is an opportunistic pathogen, primarily known for causing Progressive Multifocal Leukoencephalopathy (PML) in immunocompromised individuals.
• JCPyV is widespread, with seroprevalence reaching 85% in the adult population globally.
• Early studies suggested JCPyV's oncogenic potential through brain tumor induction in animal models, with later findings detecting viral sequences in human brain tumors.

Purpose of the Study:

• To review the multifaceted role of JCPyV in human diseases, particularly its association with various cancers.
• To elucidate the mechanisms by which JCPyV contributes to oncogenesis, focusing on the viral T-Antigen.
• To provide a comprehensive overview of JCPyV biology and its physiopathological implications.

Main Methods:

• Literature review of experimental and observational studies on JCPyV.
• Analysis of mechanistic studies detailing JCPyV's interaction with host cell pathways.
• Synthesis of evidence linking JCPyV to different types of cancer, including brain and colon tumors.

Main Results:

• JCPyV T-Antigen disrupts cell cycle regulation by targeting p53 and pRb.
• The virus activates pro-proliferative genes (e.g., c-Myc) and inhibits DNA repair mechanisms.
• JCPyV infection leads to chromosomal instability and promotes cell survival through anti-apoptotic proteins like Survivin.

Conclusions:

• JCPyV plays a significant, albeit controversial, role in the pathogenesis of human cancers, including brain and colon tumors.
• The viral T-Antigen is a key driver of oncogenesis, manipulating critical cellular pathways.
• Further research into JCPyV's oncogenic mechanisms is crucial for understanding and potentially treating virus-associated cancers.